Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Stryker Corp (SYK)

Stryker Corp (SYK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,552,080
  • Shares Outstanding, K 374,104
  • Annual Sales, $ 13,601 M
  • Annual Income, $ 3,553 M
  • 60-Month Beta 0.81
  • Price/Sales 5.93
  • Price/Cash Flow 23.03
  • Price/Book 6.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.91
  • Number of Estimates 12
  • High Estimate 1.92
  • Low Estimate 1.89
  • Prior Year 1.69
  • Growth Rate Est. (year over year) +13.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
207.19 +3.92%
on 10/02/19
223.01 -3.45%
on 09/24/19
-5.16 (-2.34%)
since 09/18/19
3-Month
204.25 +5.42%
on 08/05/19
223.45 -3.64%
on 08/30/19
+4.87 (+2.31%)
since 07/18/19
52-Week
144.75 +48.75%
on 12/26/18
223.45 -3.64%
on 08/30/19
+42.22 (+24.39%)
since 10/18/18

Most Recent Stories

More News
Tandem Rides on Strong t:slim X2 Rollout Amid Stiff Rivalry

Tandem Diabetes (TNDM) gains on strong domestic sales along with a solid international rollout of the t:slim X2 insulin pump.

VAR : 114.62 (+0.44%)
TNDM : 63.58 (+0.87%)
SYK : 215.32 (-0.11%)
MDT : 108.12 (-0.36%)
Align Rides on Volume Expansion Amid Poor Shipment Scenario

Align Technology (ALGN) is continuing with its winning streak of delivering a sturdy Invisalign Technology volume expansion across the company's entire customer base.

SYK : 215.32 (-0.11%)
MDT : 108.12 (-0.36%)
HRC : 102.03 (-0.19%)
ALGN : 213.88 (-0.02%)
CHF Solutions System to be Used in JAHVH Study After Final Nod

CHF Solutions' (CHFS) Aquadex system to be used for the outpatient study on heart failure, conducted by James A. Haley Veterans' Hospital and Clinics. The study receives final approval.

SYK : 215.32 (-0.11%)
CAPR : 2.69 (-0.74%)
GWPH : 118.11 (-0.85%)
CHFS : 1.52 (+2.70%)
Edwards Lifesciences Hits a 52-Week High on Solid Prospects

Edwards Lifesciences (EW) has been consistently delivering impressive results.

VAR : 114.62 (+0.44%)
EW : 227.46 (-0.15%)
SYK : 215.32 (-0.11%)
MDT : 108.12 (-0.36%)
Here's Why You Should Retain Henry Schein (HSIC) Stock Now

Investor confidence is still high on Henry Schein (HSIC), thanks to solid prospects.

VAR : 114.62 (+0.44%)
SYK : 215.32 (-0.11%)
MDT : 108.12 (-0.36%)
HSIC : 62.81 (-1.16%)
Phibro (PAHC) Suffers Dismal Segmental Sales, Margin Woes

Per Phibro Animal (PAHC), weak demand in Animal Health business due to swine flu outbreak in China along with an unfavorable product mix in Mineral Nutrition is dampening.

PAHC : 21.09 (-1.63%)
SYK : 215.32 (-0.11%)
GWPH : 118.11 (-0.85%)
CNAT : 0.38 (unch)
Penumbra Enrolls First Patient for Study on Coronary Vessels

Penumbra (PEN) gears up for the study of mechanical power aspiration as part of advancements in coronary treatment.

PEN : 147.21 (+0.21%)
SYK : 215.32 (-0.11%)
GWPH : 118.11 (-0.85%)
CNAT : 0.38 (unch)
Thermo Fisher Gets a Boost from Buyouts and Global Expansion

Thermo Fisher (TMO) registers a solid international performance with strong growth in Europe and Asia-Pacific including China.

TMO : 281.42 (-0.06%)
SYK : 215.32 (-0.11%)
HRC : 102.03 (-0.19%)
SYNH : 55.03 (-0.61%)
QIAGEN Down on Dim Q3 Prelim Sales, Startling CEO Departure

If the dismal preliminary sales performance was not enough, then the news pertaining to QIAGEN's (QGEN) current CEO Peer M. Schatz's stepping down came as another huge blow.

SYK : 215.32 (-0.11%)
HRC : 102.03 (-0.19%)
QGEN : 28.49 (+1.10%)
SYNH : 55.03 (-0.61%)
Medtronic Submits Two Pelvic Health Devices for FDA's PMA

Medtronic's (MDT) filing for both its InterStim products to gain FDA's PMA is its essential bid to boost its Pelvic Health & Gastric Therapies business.

SYK : 215.32 (-0.11%)
NUVA : 66.53 (+1.90%)
MDT : 108.12 (-0.36%)
AMED : 135.26 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SYK with:

Business Summary

Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital...

See More

Key Turning Points

2nd Resistance Point 216.89
1st Resistance Point 216.11
Last Price 215.32
1st Support Level 214.41
2nd Support Level 213.49

See More

52-Week High 223.45
Last Price 215.32
Fibonacci 61.8% 193.39
Fibonacci 50% 184.10
Fibonacci 38.2% 174.81
52-Week Low 144.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar